Laurent Assaraf is Principal at Ventech. He joined Ventech in 2002 and invests in Life Sciences sector. Laurent leverages his expertise in the analysis of product portfolio in the pharmaceutical industry. He is in charge of the investment in X2 Pharma and follows listed portfolio companies Evotec and Cerep.
Before he joined Ventech, Laurent was a financial analyst at oddo securities, one of the main French brokers. He was working on the analysis of pharmaceutical product portfolio well as on the assessment of their potential.
Laurent holds a Pharm-D and a MBA from IAE, Paris.
